<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
19:48
The authorities in Moldova are accused by Russia of clinging to a 'non-existent' Russian threat to distract attention from internal problems.
19:48
Eurojust explains under what conditions administrative authorities can issue European investigation orders.
19:48
Members of Colombian cartels participate as volunteers in the war in Ukraine to learn advanced drone usage techniques.
See more news